Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
02 12 2022
Historique:
received: 24 05 2022
revised: 01 08 2022
accepted: 02 09 2022
pubmed: 14 9 2022
medline: 6 12 2022
entrez: 13 9 2022
Statut: ppublish

Résumé

Melanoma is a cancer of melanocytes, with multiple subtypes based on body site location. Cutaneous melanoma is associated with skin exposed to ultraviolet radiation; uveal melanoma occurs in the eyes; mucosal melanoma occurs in internal mucous membranes; and acral melanoma occurs on the palms, soles, and nail beds. Here, we present the largest whole-genome sequencing study of melanoma to date, with 570 tumors profiled, as well as methylation and RNA sequencing for subsets of tumors. Uveal melanoma is genomically distinct from other melanoma subtypes, harboring the lowest tumor mutation burden and with significantly mutated genes in the G-protein signaling pathway. Most cutaneous, acral, and mucosal melanomas share alterations in components of the MAPK, PI3K, p53, p16, and telomere pathways. However, the mechanism by which these pathways are activated or inactivated varies between melanoma subtypes. Additionally, we identify potential novel germline predisposition genes for some of the less common melanoma subtypes. This is the largest whole-genome analysis of melanoma to date, comprehensively comparing the genomics of the four major melanoma subtypes. This study highlights both similarities and differences between the subtypes, providing insights into the etiology and biology of melanoma. This article is highlighted in the In This Issue feature, p. 2711.

Identifiants

pubmed: 36098958
pii: 709186
doi: 10.1158/2159-8290.CD-22-0603
pmc: PMC9716259
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2856-2879

Informations de copyright

©2022 The Authors; Published by the American Association for Cancer Research.

Références

Science. 2022 Apr 22;376(6591):
pubmed: 35949260
Nat Commun. 2020 Feb 5;11(1):733
pubmed: 32024817
Mol Cell. 2020 Mar 19;77(6):1307-1321.e10
pubmed: 31954095
Cancer Prev Res (Phila). 2010 Feb;3(2):233-45
pubmed: 20086181
Nat Commun. 2020 Feb 5;11(1):734
pubmed: 32024818
J Dermatol. 2005 Sep;32(9):737-44
pubmed: 16361718
Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
Nature. 2020 Feb;578(7793):122-128
pubmed: 32025013
Clin Cancer Res. 2019 Jun 15;25(12):3548-3560
pubmed: 30782616
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Bioinformatics. 2012 Jun 1;28(11):1530-2
pubmed: 22539670
Genome Biol. 2019 Oct 21;20(1):213
pubmed: 31639029
PLoS One. 2013 Nov 08;8(11):e74380
pubmed: 24250782
Cancer Discov. 2013 Oct;3(10):1122-1129
pubmed: 23861464
BMC Bioinformatics. 2020 Dec 10;21(1):571
pubmed: 33302872
Cell. 2018 Apr 5;173(2):371-385.e18
pubmed: 29625053
Science. 2013 Feb 22;339(6122):959-61
pubmed: 23348503
Nat Genet. 2018 Aug;50(8):1189-1195
pubmed: 30013179
Nat Commun. 2019 Jul 18;10(1):3163
pubmed: 31320640
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Genet. 2020 Feb;52(2):208-218
pubmed: 32015527
Genome Res. 2021 Mar;31(3):448-460
pubmed: 33441414
Cancer Cell. 2017 Aug 14;32(2):204-220.e15
pubmed: 28810145
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
Int J Cancer. 2019 Mar 1;144(5):1049-1060
pubmed: 30178487
Nature. 2010 Jan 14;463(7278):191-6
pubmed: 20016485
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Nat Genet. 2020 Dec;52(12):1373-1383
pubmed: 33230298
Mol Carcinog. 2021 Mar;60(3):167-171
pubmed: 33444485
Oncotarget. 2016 Jan 26;7(4):4624-31
pubmed: 26683228
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.9.1-15.9.17
pubmed: 27930809
J Natl Cancer Inst. 2021 Jan 4;113(1):80-87
pubmed: 32239153
PLoS One. 2013 Jun 21;8(6):e66264
pubmed: 23805207
Nat Cancer. 2020 Jun;1(6):635-652
pubmed: 35121978
Nature. 2012 May 09;485(7399):502-6
pubmed: 22622578
Nat Commun. 2020 Oct 16;11(1):5259
pubmed: 33067454
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Mol Cell. 2014 May 8;54(3):445-59
pubmed: 24746700
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Cancer Discov. 2017 Apr;7(4):410-423
pubmed: 28188128
Nature. 2022 Jun;606(7916):984-991
pubmed: 35705804
J Am Acad Dermatol. 2019 Jul;81(1):136-142.e2
pubmed: 30296542
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Pigment Cell Melanoma Res. 2017 Mar;30(2):255-258
pubmed: 28024115
Pigment Cell Melanoma Res. 2022 May;35(3):369-386
pubmed: 35229492
Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):239-46
pubmed: 8722214
J Clin Oncol. 2017 Jan 10;35(2):226-235
pubmed: 28056206
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3048-55
pubmed: 19182252
Nat Genet. 2020 Mar;52(3):331-341
pubmed: 32025003
Nat Genet. 2011 Dec 25;44(2):165-9
pubmed: 22197930
Nat Commun. 2020 May 15;11(1):2438
pubmed: 32415133
J Pathol. 2013 Jul;230(3):261-9
pubmed: 23620124
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Oncotarget. 2015 Jan 20;6(2):1115-27
pubmed: 25544760
Bioinformatics. 2019 Nov 1;35(22):4788-4790
pubmed: 31228182
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Bioinformatics. 2014 Feb 01;30(3):428-30
pubmed: 24336642
Cancer Res. 2006 Oct 15;66(20):9818-28
pubmed: 17047042
Am J Surg Pathol. 2015 Oct;39(10):1357-62
pubmed: 26076063
Nat Genet. 2014 May;46(5):478-481
pubmed: 24686849
Nat Genet. 2011 Dec 25;44(2):133-9
pubmed: 22197931
Sci Rep. 2020 Feb 12;10(1):2439
pubmed: 32051509
Cancer Discov. 2014 Jan;4(1):94-109
pubmed: 24265153
Nature. 2019 Nov;575(7781):210-216
pubmed: 31645765
Pigment Cell Melanoma Res. 2014 Sep;27(5):835-8
pubmed: 24913711
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13481-6
pubmed: 23901115
Stat Med. 1990 Jul;9(7):811-8
pubmed: 2218183
Commun Biol. 2020 Apr 2;3(1):153
pubmed: 32242091
Nat Commun. 2014 Oct 29;5:5224
pubmed: 25351503
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Nat Genet. 2011 Aug 28;43(10):1018-21
pubmed: 21874003
Nat Genet. 2017 Mar;49(3):349-357
pubmed: 28135248
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Nat Genet. 2011 May;43(5):442-6
pubmed: 21499247
Nat Commun. 2016 Jul 12;7:12064
pubmed: 27403562
PLoS One. 2018 Apr 11;13(4):e0194098
pubmed: 29641532
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
Nat Genet. 2020 May;52(5):494-504
pubmed: 32341527
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nature. 2011 Nov 13;480(7375):99-103
pubmed: 22080950
Nat Genet. 2002 May;31(1):55-9
pubmed: 11967536
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nature. 2020 Feb;578(7793):102-111
pubmed: 32025015
Nat Genet. 2012 Sep;44(9):1006-14
pubmed: 22842228
J Pathol. 2018 Mar;244(3):358-366
pubmed: 29230811
N Engl J Med. 2005 Nov 17;353(20):2135-47
pubmed: 16291983
Nucleic Acids Res. 2015 Sep 30;43(17):8123-34
pubmed: 26304545
Melanoma Res. 2017 Jun;27(3):189-199
pubmed: 28296713
Pigment Cell Melanoma Res. 2012 Jul;25(4):488-92
pubmed: 22578220
Nat Genet. 2014 Oct;46(10):1060-2
pubmed: 25194279
Science. 2010 Dec 3;330(6009):1410-3
pubmed: 21051595
Ophthalmology. 2016 May;123(5):1118-28
pubmed: 26923342
Nat Commun. 2021 Mar 4;12(1):1434
pubmed: 33664264
Clin Cancer Res. 2021 Apr 15;27(8):2226-2235
pubmed: 33509808
Mol Cancer Res. 2021 Jun;19(6):991-1004
pubmed: 33707307
Am J Surg Pathol. 2018 Aug;42(8):1052-1058
pubmed: 29683819
Blood. 2018 Oct 4;132(14):1526-1534
pubmed: 30049810
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Genome Med. 2022 Jun 16;14(1):65
pubmed: 35706047
Genome Biol. 2013 Sep 24;14(9):r105
pubmed: 24063430
Nat Commun. 2021 Jan 11;12(1):259
pubmed: 33431815
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Nat Commun. 2020 May 15;11(1):2408
pubmed: 32415113
Genome Biol. 2016 Jun 16;17(1):128
pubmed: 27311963
Nat Genet. 2013 Aug;45(8):933-6
pubmed: 23793026
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
Nucleic Acids Res. 2017 Feb 28;45(4):e22
pubmed: 27924034
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Leukemia. 2015 May;29(5):1092-103
pubmed: 25428262
Oncogene. 1996 Jun 20;12(12):2527-33
pubmed: 8700511

Auteurs

Felicity Newell (F)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Peter A Johansson (PA)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

James S Wilmott (JS)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Katia Nones (K)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Vanessa Lakis (V)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Antonia L Pritchard (AL)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Department of Genetics and Immunology, Division of Biomedical Science, University of the Highlands and Islands, Inverness, Scotland, United Kingdom.

Serigne N Lo (SN)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.

Robert V Rawson (RV)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.

Stephen H Kazakoff (SH)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Andrew J Colebatch (AJ)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.

Lambros T Koufariotis (LT)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Peter M Ferguson (PM)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.

Scott Wood (S)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Conrad Leonard (C)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Matthew H Law (MH)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia.

Kelly M Brooks (KM)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Natasa Broit (N)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Q-Gen Cell Therapeutics, Brisbane, Queensland, Australia.

Jane M Palmer (JM)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Kasey L Couts (KL)

Center for Rare Melanomas, University of Colorado Cancer Center, Aurora, Colorado.

Ismael A Vergara (IA)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Georgina V Long (GV)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Mater Hospital, North Sydney, New South Wales, Australia.
Royal North Shore Hospital, St Leonards, New South Wales, Australia.

Andrew P Barbour (AP)

Diamantina Institute, The University of Queensland, Brisbane, Queensland, Australia.

Omgo E Nieweg (OE)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Brindha Shivalingam (B)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Mater Hospital, North Sydney, New South Wales, Australia.
Department of Neurosurgery, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
Department of Neurosurgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

William A Robinson (WA)

Center for Rare Melanomas, University of Colorado Cancer Center, Aurora, Colorado.

Jonathan R Stretch (JR)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Mater Hospital, North Sydney, New South Wales, Australia.
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Andrew J Spillane (AJ)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Mater Hospital, North Sydney, New South Wales, Australia.
Royal North Shore Hospital, St Leonards, New South Wales, Australia.

Robyn P M Saw (RPM)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Mater Hospital, North Sydney, New South Wales, Australia.
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Kerwin F Shannon (KF)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

John F Thompson (JF)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Mater Hospital, North Sydney, New South Wales, Australia.
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Graham J Mann (GJ)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.

John V Pearson (JV)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Richard A Scolyer (RA)

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.

Nicola Waddell (N)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Nicholas K Hayward (NK)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH